These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2952510

  • 21. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 22. Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity.
    Do JS, Choi YH, Shin SH, Yi HK, Hwang PH, Nam SY.
    Immunol Lett; 2004 Aug 15; 95(1):77-84. PubMed ID: 15325801
    [Abstract] [Full Text] [Related]

  • 23. Rescue of the tumor-specific immune response of aged mice in vitro.
    Urban JL, Schreiber H.
    J Immunol; 1984 Jul 15; 133(1):527-34. PubMed ID: 6609995
    [Abstract] [Full Text] [Related]

  • 24. Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo.
    Ley V, Langlade-Demoyen P, Kourilsky P, Larsson-Sciard EL.
    Eur J Immunol; 1991 Mar 15; 21(3):851-4. PubMed ID: 2009918
    [Abstract] [Full Text] [Related]

  • 25. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF, Nossal GJ.
    J Immunol; 1983 Dec 15; 131(6):2662-9. PubMed ID: 6227660
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW, Romerdahl CA, Kripke ML.
    Cancer Res; 1989 Mar 01; 49(5):1207-13. PubMed ID: 2465081
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Proliferative and cytotoxic immune functions in aging mice. IV. Effects of suppressor cell populations from aged and young mice.
    Gottesman SR, Edington JM, Thorbecke GJ.
    J Immunol; 1988 Mar 15; 140(6):1783-90. PubMed ID: 2964484
    [Abstract] [Full Text] [Related]

  • 31. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 32. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, Colombo MP.
    Eur J Immunol; 1995 Jan 15; 25(1):137-46. PubMed ID: 7843224
    [Abstract] [Full Text] [Related]

  • 33. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
    Naito K, Nomi S, Komichi H, Ueda Y, Yamagishi H, Oka T, Pellis NR, Kahan BD.
    Cancer Detect Prev; 1992 Jan 15; 16(5-6):321-7. PubMed ID: 1361881
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
    Miki S, Ksander B, Streilein JW.
    Reg Immunol; 1992 Jan 15; 4(6):352-62. PubMed ID: 1297406
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 40. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes.
    Lynch DH, Namen AE, Miller RE.
    Eur J Immunol; 1991 Dec 15; 21(12):2977-85. PubMed ID: 1684156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.